Diazepam-Lipuro | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Diazepam-Lipuro
US Patents

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Diazepam-Lipuro

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 7 USDMF, 4 CEP/COS, 2 JDMF, 4 EU WC, 9 NDC API, 14 Listed Suppliers, $ API Reference Price

23 API Suppliers
7 USDMF
4 CEP/COS
2 JDMF
4 EU WC
9 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

362 FDF Dossiers, 129 FDA Orange Book, 129 Europe, 15 Canada, 31 Australia, 18 South Africa, 40 Listed Dossiers

362 FDF Dossiers
129 FDA Orange Book
129 Europe
15 Canada
31 Australia
18 South Africa
40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG, GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 2.5MG/0.5ML (5MG/ML), GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 2MG
TABLET;ORAL - 5MG
GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)
GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 2 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 26 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 21 Direct Compression, 21 Thickeners and Stabilizers, 19 Granulation, 18 Lubricants & Glidants, 18 Film Formers & Plasticizers, 16 Topical, 13 Taste Masking, 11 Co-Processed Excipients, 9 Solubilizers, 8 Chewable & Orodispersible Aids, 7 Parenteral, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

61 Fillers, Diluents & Binders
47 Coating Systems & Additives
26 Disintegrants & Superdisintegrants
25 Controlled & Modified Release
21 Direct Compression
21 Thickeners and Stabilizers
19 Granulation
18 Lubricants & Glidants
18 Film Formers & Plasticizers
16 Topical
13 Taste Masking
11 Co-Processed Excipients
9 Solubilizers
8 Chewable & Orodispersible Aids
7 Parenteral
6 Emulsifying Agents
6 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
2 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 72 News #PharmaBuzz

1 Data Compilation #PharmaFlow
72 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 136 Regulatory FDF Prices, 3 Annual Reports

4 US Medicaid Prescriptions
136 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

31 APIs
24 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents, 6 US Exclusivities, 1 Health Canada Patents

24 US Patents
6 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 10 Others

2 EDQM
10 Others

$ API Ref.Price (USD/KG) : 269 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

24 All

01 24NEURELIS INC

filter Patent Number Reset all filters

24 All

01 38895546

02 68927497

03 39642913

04 310265402

05 311241414

06 311793786

07 312268664

API Patent Reset all filters

24 All

01 24Blank

filter FDF Patent Reset all filters

24 All

01 24Y

filter Expiration Date Reset all filters

24 All

01 62025-05-11

02 62025-07-21

03 122029-03-27

Product Main Page

01

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-2727

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-2727

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-2727

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-4173

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-4173

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-21

US Patent Number : 8927497

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code : U-4173

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-07-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-05-11

US Patent Number : 9642913

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-05-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-27

US Patent Number : 12268664

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-27

US Patent Number : 11793786

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

NEURELIS INC

IMCAS Asia

Not Confirmed

NEURELIS INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-05-11

US Patent Number : 10265402

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211635

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-05-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!